{"aaData": [["NOT APPLICABLE FOR THIS SITE", "", "
1
\n"], ["PLEURAL EFFUSION", "
\n
\n\n
\n", "
1
\n"], ["MEASURED THICKNESS (DEPTH), BRESLOW'S MEASUREMENT", "", "
1
\n"], ["PERIPHERAL BLOOD INVOLVEMENT", "", "
1
\n"], ["EXTENSION EVALUATED AT ENUCLEATION", "", "
1
\n"], ["WHO GRADE CLASSIFICATION", "
\n
\n\n
\n", "
1
\n"], ["ASSOCIATED WITH HIV/AIDS", "", "
1
\n"], ["SOLITARY VS MULTIFOCAL", "
\n
\n\n
\n", "
1
\n"], ["EXTRACAPSULAR EXTENSION, LYMPH NODES FOR HEAD AND NECK", "
\n
\n\n
\n", "
2
\n"], ["FIBROSIS SCORE", "
\n
\n\n
\n", "
2
\n"], ["ULCERATION", "", "
2
\n"], ["CARCINOEMBRYONIC ANTIGEN (CEA)", "
\n
\n\n
\n", "
1
\n"], ["PROGESTERONE RECEPTOR ASSAY (PRA)", "
\n
\n\n
\n", "
2
\n"], ["PROSTATIC SPECIFIC ANTIGEN - (PSA)", "
\n
\n\n
\n", "
2
\n"], ["HUMAN CHORIONIC GONADOTROPIN (HCG)", "
\n
\n\n
\n", "
2
\n"], ["SYSTEMIC SYMPTOMS AT DIAGNOSIS", "", "
2
\n"], ["LEVELS I-III, LYMPH NODES FOR HEAD AND NECK", "
\n
\n\n
\n", "
3
\n"], ["CLINICAL STATUS OF LYMPH NODE METS", "", "
3
\n"], ["NUMBER OF POSITIVE IPSILATERAL AXILLARY LYMPH NODES", "
\n
\n\n
\n", "
3
\n"], ["CS EXTENSION - PATHOLOGIC EXTENSION", "
\n
\n\n
\n", "
3
\n"], ["LDH", "", "
4
\n"], ["IPI SCORE", "", "
3
\n"], ["ALPHA FETOPROTEIN (AFP)", "
\n
\n\n
\n", "
1
\n"], ["LEVELS IV-V AND RETROPHARYNGEAL LYMPH NODES FOR HEAD AND NECK", "
\n
\n\n
\n", "
4
\n"], ["PROSTATE APEX INVOLVEMENT", "
\n
\n\n
\n", "
4
\n"], ["IMMUNOHISTOCHEMISTRY (IHC) OF REGIONAL LYMPH NODES", "
\n
\n\n
\n", "
4
\n"], ["PROSTATE APEX INVOLVEMENT", "
\n
\n\n
\n", "
4
\n"], ["RADICAL ORCHIECTOMY PERFORMED", "
\n
\n\n
\n", "
4
\n"], ["LEVELS VI-VII AND FACIAL LYMPH NODES FOR HEAD AND NECK", "
\n
\n\n
\n", "
5
\n"], ["PARAPHARYNGEAL, PAROTID, PREAURICULAR, & SUB-OCCIPITAL LYMPH NODES", "
\n
\n\n
\n", "
6
\n"], ["MOLECULAR STUDIES OF REGIONAL LYMPH NODES", "
\n
\n\n
\n", "
5
\n"], ["SIZE OF TUMOR--INVASIVE COMPONENT", "
\n
\n\n
\n", "
6
\n"], ["GLEASON'S PRIMARY PATTERN AND SECONDARY PATTERN SCORE", "
\n
\n\n
\n", "
5
\n"], ["ESTROGEN RECEPTOR ASSAY (ERA)", "
\n
\n\n
\n", "
1
\n"], ["GLEASON'S SCORE", "
\n
\n\n
\n", "
6
\n"], ["SIZE OF METASTASIS IN LYMPH NODES", "
\n
\n\n
\n", "
5
\n"], ["CLINICAL ASSESSMENT OF REGIONAL LYMPH NODES", "
\n
\n\n
\n", "
2
\n"], ["CLINICAL ASSESSMENT OF REG LYMPH NODES", "
\n
\n\n
\n", "
1
\n"], ["CARBOHYDRATE ANTIGEN 125 (CA-125)", "
\n
\n\n
\n", "
1
\n"], ["SIZE OF LYMPH NODES", "
\n
\n\n
\n", "
1
\n"], ["ALPHA FETOPROTEIN - (AFP)", "
\n
\n\n
\n", "
1
\n"], ["PROSTATIC SPECIFIC ANTIGEN (PSA) LAB VALUE", "
\n
\n\n
\n", "
1
\n"], ["PROGNOSTIC SCORING INDEX TABLE 1", "
\n
\n\n
\n", "
1
\n"]]}